Leveraging a synthetic biology approach to enhance BCG-mediated expansion of Vγ9Vδ2 T cells
Christine M. Qabar, Allison W. Roberts, Lucas M. Waldburger, Edward E. K. Baidoo, Emine Akyuz Turumtay, Jay D. Keasling, Dan A. Portnoy, Jeffery S. Cox
This paper uses synthetic biology to engineer BCG to produce HMBPP, enhancing Vγ9Vδ2 T cell expansion without feedback inhibition, offering a strategy to improve TB vaccine efficacy.
PLoS ONE · Apr 6, 2026Peer-reviewedBioengineering